Condensed Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
Current Assets:
Cash and cash equivalents	$ 986,905	$ 3,318,155
Trade receivables	1,254,742	458,076
Related party receivables and deposits	134,200	21,122
Inventories	2,082,935	1,887,612
Prepaid expenses and other current assets	2,539,913	1,157,484
Total current assets	6,998,695	6,842,449
Property, Plant and Equipment:	38,682,059	38,614,905
Less accumulated depreciation and amortization	(22,299,012)	(17,850,688)
Net property, plant and equipment	16,383,047	20,764,217
Other Assets:
Patents, net of amortization of $112,889 and $83,364, respectively	1,212,792	879,541
Other non-current assets	221,000	52,813
Total Other Assets	1,433,792	932,354
Total Assets	24,815,534	28,539,020
Current Liabilities:
Accounts payable	1,667,491	442,754
Accrued expenses	2,546,820	1,800,369
Current portion of long-term debt	297,278	282,960
Current Portion of Litigation Settlement	482,519	0
Make-whole dividend liability	1,668,510	3,146,156
Total current liabilities	6,662,618	5,672,239
Accrued Litigation Settlement, net of current portion	1,008,479	1,317,500
Long-Term Debt, net of current portion	5,842,392	6,067,175
Accrued Warranty Liability	91,000	47,937
Commitments and Contingencies (Notes 4 & 12)
Stockholders’ Equity:
Common stock, $0.0001 par value, 250,000,000 shares authorized; 14,137,138 and 6,174,853 shares issued and outstanding, respectively	1,414	617
Additional paid in capital	298,576,587	263,275,563
Deficit accumulated during the development stage	(287,366,977)	(247,842,047)
Total stockholders’ equity	11,211,045	15,434,169
Total Liabilities and Stockholders’ Equity	$ 24,815,534	$ 28,539,020